Keynote with the CEO of Edwards Lifesciences and Managing Partner & COO of SV Health Investors | LSI USA '24

Bernard J. Zovighian, age 55, is Chief Executive Officer of Edwards Lifesciences, and became a director of the Company in 2023.  Prior to becoming CEO in 2023, Mr. Zovighian served as President. He joined Edwards Lifesciences in January 2015 as Vice President and General Manager of the Surgical Structural Heart business. He later served as Corporate Vice President of the surgical business from 2016 until January 2018, when he became Corporate Vice President responsible for the company’s Transcatheter Mitral and Tricuspid Therapies (TMTT) business. In his nearly 30-year career in medical technology, Mr. Zovighian spent 12 years leading global businesses across two world-class companies. Before joining Edwards, Mr. Zovighian held roles with increasing levels of responsibility at Johnson & Johnson (J&J) for nearly 20 years, including regional leadership outside of the United States and worldwide president of one of the company’s divisions. He has dual master’s degrees in science and business from Universities of Marseille, France.

Paul brings over 35 years of global medical technology management experience to SV.

He joined SV in 2009 as a Venture Partner and in 2011 was made a Partner. Paul was promoted to Managing Partner & COO in 2014 and heads our medical device investments.

Prior to SV, Paul built and ran medical device businesses for 29 years before joining SV Health Investors. Most recently he was Chief Operating Officer at Boston Scientific (BSC), an $8 billion medical device leader. During his 15 years at BSC, Paul served as Chief Operating Officer; Group President, Cardiovascular; President, Cardiology; Group President, Endosurgery; and President, International. During his tenure, the company grew revenue over 20 times. Paul integrated two dozen acquisitions and led extensive product development, manufacturing and worldwide commercial organizations. Previously, Paul held marketing and general management positions at CR Bard and various marketing roles at Kendall (Medtronic).

Outside of SV, Paul serves on the board of Edwards Lifesciences Corporation and the Medical Device Manufacturers Association, and is Chairman of the Innovation Growth Board at the Mass General Brigham health system. In addition, Paul serves on the board of Vibrato Medical, Inc. as a Director. He also served on the board of Advamed for 10 years and is a routine speaker at industry meetings.